Evidence map›Paper›PMID 38413235›Full record

ArticleInternational journal of spine surgery2024

Cervical Disc Arthroplasty: Rationale, Designs, and Results of Randomized Controlled Trials.

Djani M Robertson, Andy Ton, Michael Brown, Shane Shahrestani, Emily S Mills, Jeffrey C Wang, Raymond J Hah, Ram K Alluri

Open access · diamondAbstract read
In one paragraph

Article in International journal of spine surgery, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Djani M RobertsonDepartment of Orthopedic Surgery, NYU Langone Medical Center, New York, NY, USA.
Andy TonDepartment of Orthopedic Surgery, Keck Medical Center of USC, Los Angeles, CA, USA andyton@usc.edu.
Michael BrownDepartment of Orthopedic Surgery, Keck Medical Center of USC, Los Angeles, CA, USA.
Shane ShahrestaniDepartment of Orthopedic Surgery, Keck Medical Center of USC, Los Angeles, CA, USA.
Emily S MillsDepartment of Orthopedic Surgery, Keck Medical Center of USC, Los Angeles, CA, USA.
Jeffrey C WangDepartment of Orthopedic Surgery, Keck Medical Center of USC, Los Angeles, CA, USA.
Raymond J HahDepartment of Orthopedic Surgery, Keck Medical Center of USC, Los Angeles, CA, USA.
Ram K AlluriDepartment of Orthopedic Surgery, Keck Medical Center of USC, Los Angeles, CA, USA.
Keck Hospital of USC · USNYU Langone Health · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThis review outlines clinical data and characteristics of current Food and Drug Administration (FDA)-approved implants in cervical disc replacement/cervical disc arthroplasty (CDR/CDA) to provide a centralized resource for spine surgeons.

methodsRandomized controlled trials (RCTs) on CDR/CDA were identified using a search of the PubMed, Web of Science, and Google Scholar databases. The initial search identified 69 studies. Duplicates were removed, and the following inclusion criteria were applied when determining eligibility of RCTs for the current review: (1) discussing CDR/CDA prosthesis and (2) published within between 2010 and 2020. Studies without clinical data or that were not RCTs were excluded. All articles were reviewed independently by 2 authors, with the involvement of an arbitrator to facilitate consensus on any discrepancies.

resultsA total of 34 studies were included in the final review. Findings were synthesized into a comprehensive table describing key features and clinical results for each FDA-approved CDR/CDA implant and are overall suggestive of expanding indications and increasing utilization.

conclusionsRCTs have provided substantial evidence to support CDR/CDA for treating single- and 2-level cervical degenerative disc disease in place of conventional anterior cervical discectomy and fusion. CLINICAL RELEVANCE: This review provides a resource that consolidates relevant clinical data for current FDA-approved implants to help spine surgeons make an informed decision during preoperative planning. LEVEL OF EVIDENCE: 5:

Indexed as

anterior cervical discectomy and fusioncervical, cervical disc arthroplastycervical disc replacementdegenerative disc diseasemyelopathy

Identifiers

PMID38413235
PMCPMC11535766
OpenAlexW4392188818

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.